Skip to main content

Azathioprine News

FDA Medwatch Alert: FDA Alerts Health Care Professionals of Pregnancy Problems Associated with Thiopurines

April 29, 2024 – FDA is alerting health care professionals of the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines (azathioprine, 6-mercaptopurine, and...

FDA Medwatch Alert: Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: Update on Reports of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults

  [UPDATED 11/04/2011]  Healthcare professionals should remain vigilant for cases of malignancy in patients treated with TNF blockers, and report such cases to MedWatch. The reports should include: p...

FDA Medwatch Alert: Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: Update on Reports of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults

[Posted 04/14/2011] ISSUE: FDA continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL, primarily in adolescents and young adults being...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Contact Dermatitis, Atopic Dermatitis, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Myasthenia Gravis, Multiple Sclerosis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Eczema, Crohn's Disease - Maintenance, Crohn's Disease

Azathioprine patient information at Drugs.com